High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer

被引:15
作者
He, Xigang [1 ]
Xu, Xueliang [2 ]
Khan, Abdul Qadir [3 ]
Ling, Wei [2 ]
机构
[1] Rizhao Lanshan Peoples Hosp, Dept Resp Med, Rizhao, Shandong, Peoples R China
[2] Linyi Peoples Hosp, Dept Resp Med, Linyi, Shandong, Peoples R China
[3] Shandong Univ, Dept Gen Surg, Qilu Hosp, Jinan, Shandong, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2017年 / 23卷
关键词
Lung Neoplasms; Neoplasms; Squamous Cell; Prognosis; S100; Proteins; CALCIUM-BINDING PROTEIN; EARLY-STAGE; COLORECTAL-CANCER; POOR-PROGNOSIS; CARCINOMA; CHOLANGIOCARCINOMA; PROGRESSION; METASTASIS; PATHWAYS; SURVIVAL;
D O I
10.12659/MSM.904279
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: S100 family of proteins is mainly involved in regulation of intracellular calcium homeostasis. Aberrant expression of S100 family members has been reported in many types of cancers. However, as a member of S100 family, the prognostic value of S100A6 for lung squamous cell carcinoma (SCC) has not been well-studied. Material/Methods: Using immunohistochemistry, we investigated the expression of S100A6 in 177 patients with SCC and further divided the cohort into a high S100A6 expression group and a low S100A6 expression group. The chi-square test was applied to analyze the correlation between S100A6 expression and clinicopathological factors. Univariate analysis using the Kaplan-Meier method was performed to compare the difference in survival rates between the high S100A6 expression group and the low S100A6 expression group; multivariate analysis with Cox regression model was used to identify independent prognostic risk factors. Results: In our experiment, we demonstrated that the expression of S100A6 was significantly associated with patient age and tumor differentiation. High-expression of S100A6 was shown to be substantially related to the unfavorable prognosis of SCC. Moreover, our results confirmed that S100A6 was an independent risk factor for SCC prognosis, and could predict unfavorable prognosis. Conclusions: High-expression of S100A6 was identified as an independent unfavorable prognostic factor for SCC, suggesting that targeting S100A6 may result in the development of potential targeted drug for SCC.
引用
收藏
页码:5011 / 5017
页数:7
相关论文
共 34 条
[1]   S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: Impairment by advanced tumour stages and neoadjuvant chemotherapy [J].
Bartling, Babett ;
Rehbein, Grit ;
Schmitt, Wolfgang Daniel ;
Hofmann, Hans-Stefan ;
Silber, Rolf-Edgar ;
Simm, Andreas .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (13) :1935-1943
[2]  
Bir F, 2014, MED SCI MONITOR, V20, P219, DOI 10.12659/MSM.890394
[3]   S100 Calcium-Binding Protein A6 Promotes Epithelial-Mesenchymal Transition through β-Catenin in Pancreatic Cancer Cell Line [J].
Chen, Xue ;
Liu, Xinjuan ;
Lang, Haibo ;
Zhang, Shiqi ;
Luo, Yanlin ;
Zhang, Jie .
PLOS ONE, 2015, 10 (03)
[4]   Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers [J].
Cross, SS ;
Hamdy, FC ;
Deloulme, JC ;
Rehman, I .
HISTOPATHOLOGY, 2005, 46 (03) :256-269
[5]  
DAVIES BR, 1993, ONCOGENE, V8, P999
[6]   Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer [J].
De Petris, Luigi ;
Orre, Lukas M. ;
Kanter, Lena ;
Pernemalm, Maria ;
Koyi, Hirsh ;
Lewensohn, Rolf ;
Lehtio, Janne .
LUNG CANCER, 2009, 63 (03) :410-417
[7]   S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer [J].
Diederichs, S ;
Bulk, E ;
Steffen, B ;
Ji, P ;
Tickenbrock, L ;
Lang, K ;
Zänker, KS ;
Metzger, R ;
Schneider, PM ;
Gerke, V ;
Thomas, M ;
Berdel, WE ;
Serve, H ;
Müller-Tidow, C .
CANCER RESEARCH, 2004, 64 (16) :5564-5569
[8]   Somatic mutations affect key pathways in lung adenocarcinoma [J].
Ding, Li ;
Getz, Gad ;
Wheeler, David A. ;
Mardis, Elaine R. ;
McLellan, Michael D. ;
Cibulskis, Kristian ;
Sougnez, Carrie ;
Greulich, Heidi ;
Muzny, Donna M. ;
Morgan, Margaret B. ;
Fulton, Lucinda ;
Fulton, Robert S. ;
Zhang, Qunyuan ;
Wendl, Michael C. ;
Lawrence, Michael S. ;
Larson, David E. ;
Chen, Ken ;
Dooling, David J. ;
Sabo, Aniko ;
Hawes, Alicia C. ;
Shen, Hua ;
Jhangiani, Shalini N. ;
Lewis, Lora R. ;
Hall, Otis ;
Zhu, Yiming ;
Mathew, Tittu ;
Ren, Yanru ;
Yao, Jiqiang ;
Scherer, Steven E. ;
Clerc, Kerstin ;
Metcalf, Ginger A. ;
Ng, Brian ;
Milosavljevic, Aleksandar ;
Gonzalez-Garay, Manuel L. ;
Osborne, John R. ;
Meyer, Rick ;
Shi, Xiaoqi ;
Tang, Yuzhu ;
Koboldt, Daniel C. ;
Lin, Ling ;
Abbott, Rachel ;
Miner, Tracie L. ;
Pohl, Craig ;
Fewell, Ginger ;
Haipek, Carrie ;
Schmidt, Heather ;
Dunford-Shore, Brian H. ;
Kraja, Aldi ;
Crosby, Seth D. ;
Sawyer, Christopher S. .
NATURE, 2008, 455 (7216) :1069-1075
[9]   S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles [J].
Donato, R .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (07) :637-668
[10]   S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways [J].
Duan, Liang ;
Wu, Rui ;
Zou, Zhengyu ;
Wang, Haiyan ;
Ye, Liwei ;
Li, Huan ;
Yuan, Shimei ;
Li, Xueru ;
Zha, He ;
Sun, Hui ;
Zhang, Yunyuan ;
Chen, Xian ;
Zhou, Lan .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) :781-790